1. Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G et al (2011) Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol Off J Am Soc Clin Oncol 29(20):2773–2780
2. Avizonis VN, Sause WT, Noyes RD (1989) Morbidity and mortality associated with intraoperative radiotherapy. J Surg Oncol 41(4):240–245
3. Azinovic I, Calvo FA, Puebla F, Aristu J, Martinez-Monge R (2001) Long-term normal tissue effects of intraoperative electron radiation therapy (IOERT): late sequelae, tumor recurrence, and second malignancies. Int J Radiat Oncol Biol Phys 49(2):597–604
4. Bebenek M, Pudelko M, Cisarz K, Balcerzak A, Tupikowski W, Wojciechowski L et al (2007) Therapeutic results in low-rectal cancer patients treated with abdominosacral resection are similar to those obtained by means of anterior resection in mid- and upper-rectal cancer cases. Eur J Surg Oncol J Eur Soc Surg Oncol Brit Assoc Surg Oncol 33(3):320–323
5. Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, et al (2004) Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract 8(1):56–62 (discussion-3)